JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 26 No. 1 9-16
© 1985 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by von Schulthess, G. K.
Right arrow Articles by Bekier, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by von Schulthess, G. K.
Right arrow Articles by Bekier, A.

Regional Quantitative Noninvasive Assessment of Cerebral Perfusion and Function with N-Isopropyl-[123I]p-Iodoamphetamine

G. K. von Schulthess*,, E. Ketz, P. A. Schubiger and A. Bekier

Institute of Nuclear Medicine and Department of Neurology, Kantonsspital, 9007 St. Gallen, Switzerland
Swiss Federal Institute for Reactor Research (EIR)3, 5303 Wuerenlingen, Switzerland

Correspondence: For reprints contact: Gustav K. von Schulthess MD, PhD, Dept. of Radiology, University Hospital, 8091 Zurich, Switzerland.

ABSTRACT

Although several reports on the clinical usefulness of N-isopropyl-[123I]p-iodoamphetamine (IMP) in the diagnosis of cerebral disease have appeared in the literature, quantitative, noninvasive measurements of regional cerebral blood flow with this method pose difficulties because cerebral IMP uptake not only depends on cerebral perfusion but also on cerebral function. Rather than trying to develop a method to measure cerebral perfusion with IMP, we have chosen to test a method to quantitatively evaluate planar and emission computed tomographic (ECT) studies by comparing the data obtained in patients with established pathology (n = 51, number of scans = 54) with the data obtained in a group of normal individuals (n = 10, number of scans = 11). Using this method, absolute cerebral IMP uptake (counts/pixel/mCi/min) and planar anterior right-left ratios were obtained. Also measured were right-left ratios obtained from 12 paired regions in three ECT slices. In the control group, we found an IMP uptake of 35.6 ± 4.3 cts/pixel/mCi/min and right-left ratios around 1.00 (s.d. <2%). The evaluation of the patients cerebral IMP uptake asymmetries relative to the normal standard values is a useful adjunct to qualitative image analysis in assessing the presence and severity of disease, as qualitative analysis is prone to false-positive and negative results. Cerebral IMP uptake as measured in cts/pixel/mCi/min is abnormal only in severe cerebral disease and therefore generally a less helpful parameter.

FOOTNOTES

* Present address: Dept. of Radiology, Univ. of California, San Francisco, CA 94143; on leave of absence from Dept. of Radiology, Univ. Hospital, 8091 Zurich, Switzerland.




This article has been cited by other articles:


Home page
ANGIOLOGYHome page
R. L. Levine, J. M. Rozental, and R. J. Nickles
Blood Flow Asymmetry in Carotid Occlusive Disease
Angiology, February 1, 1992; 43(2): 100 - 109.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1985 by the Society of Nuclear Medicine.